{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-000987","form_type":"8-K","ticker":"WGRX","cik":"0002030763","company_name":"Wellgistics Health, Inc.","filed_at":"2025-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.833553+00:00","generated_at":"2026-05-24T04:24:41.768069+00:00","sec_items":["3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Wellgistics grants 19.8M shares of restricted stock; reports pro forma 2024 revenue of $45.7M","bullets":["Granted 19,764,108 restricted shares under the 2023 Equity Plan, including 9M to CEO vesting on financial metrics for FY2025-2027.","Pro forma consolidated net sales for 2024 were $45.7M, a 33% increase over 2023, assuming recent acquisitions occurred Jan 1, 2023.","Launched EinsteinRx, an AI-driven decision support software integrated into the Wellgistics Hub prescription platform.","Aims to onboard 5,000 pharmacies by mid-2026 and grow active patient base 10x by year-end.","Plans multiple tech-driven acquisitions and predictive care AI for customer service and benefits verification."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-000987","json":"https://secwatch.observer/filing/0001641172-25-000987.json","markdown":"https://secwatch.observer/filing/0001641172-25-000987.md","text":"https://secwatch.observer/filing/0001641172-25-000987.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030763/000164117225000987/0001641172-25-000987-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030763/000164117225000987/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T04:24:41.768069+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}